Association of Tumor Mutation Burden and Epidermal Growth Factor Receptor Inhibitor History With Survival in Patients With Metastatic Stage III IV Nonsmall-Cell Lung Cancer: A Retrospective Study. Clinics 2021, 76, e2251. https://doi.org/10.6061/clinics/2021/e2251.